推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

NEUROPHARMACOLOGY

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 NEUROPHARMACOLO最新评论:手稿有专门的期刊模板吗,还在按照要求自己写 (2023-05-31)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


NEUROPHARMACOLOGY期刊基本信息Hello,您是该期刊的第89511位访客

基本信息 登录收藏
期刊名字NEUROPHARMACOLOGYNEUROPHARMACOLOGY

NEUROPHARMACOLOGY
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.0
56人评分
我要评分

声誉
8.8

影响力
6.9

速度
9.4

期刊ISSN0028-3908
微信扫码收藏此期刊
E-ISSN1873-7064
2022-2023最新影响因子
(数据来源于搜索引擎)
4.7 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:3.919
2022-2023自引率4.30%点击查看自引率趋势图
五年影响因子4.8
h-index 150
CiteScore
CiteScoreSJRSNIPCiteScore排名
9.801.3071.120
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q140 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Cellular and Molecular Neuroscience
Q116 / 90

期刊简介
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
期刊官方网站http://www.journals.elsevier.com/neuropharmacology/
期刊投稿网址https://www.editorialmanager.com/NEUROPHARM
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足NEUROPHARMACOLOGY的语言要求,还能让NEUROPHARMACOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被NEUROPHARMACOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB
出版商Elsevier Ltd
涉及的研究方向医学-神经科学
出版国家或地区ENGLAND
出版语言English
出版周期Semimonthly
出版年份1970
年文章数 258点击查看年文章数趋势图
Gold OA文章占比12.28%
研究类文章占比:
文章 ÷(文章 + 综述)
99.22%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:NEUROSCIENCES
类别:SCIE
Q285/272
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q169/277
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区2区3区
PHARMACOLOGY & PHARMACY
药学
3区1区2区
NEUROSCIENCES
神经科学
3区2区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区3区
NEUROSCIENCES
神经科学
1区3区2区
PHARMACOLOGY & PHARMACY
药学
1区3区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区4区
NEUROSCIENCES
神经科学
3区3区2区
PHARMACOLOGY & PHARMACY
药学
3区2区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0028-3908%5BISSN%5D
平均审稿速度网友分享经验:
平均1.0个月
平均录用比例网友分享经验:
约75%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在NEUROPHARMACOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 NEUROPHARMACOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 NEUROPHARMACOLOGY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
NEUROPHARMACOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS NEUROSCIENCE35732.40
    NATURE NEUROSCIENCE37543.90
    Neuron43026.90
    TRENDS IN NEUROSCIENCES26925.70
    Molecular Neurodegeneration6625.00
    Annual Review of Neuroscience22424.40
    Journal of Neuroinflammation9215.00
    PROGRESS IN NEUROBIOLOGY21215.20
    GLIA14814.00
    Journal of Neuroimmune Pharmacology6412.20
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599851
    BIOMATERIALS512715
    BIOMEDICINE & PHARMACOTHERAPY461872
    Journal of Materials Chemistry B458413
    Frontiers in Pharmacology448222
    Frontiers in Immunology419219
    JOURNAL OF ETHNOPHARMACOLOGY403604
    COLLOIDS AND SURFACES B-BIOINTERFACES403093
    Frontiers in Oncology382530
    Acta Biomaterialia374633
  •  

    NEUROPHARMACOLOGY NEUROPHARMACOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Reduced inhibitory and excitatory input onto parvalbumin interneurons mediated by perineuronal net might contribute to cognitive impairments in a mouse model of sepsis-associated encephalopathy

    Author: Zhang, Ling; Gao, Yu-Zhu; Zhao, Chun-Jie; Xia, Jiang-Yan; Yang, Jian-Jun; Ji, Mu-Huo
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 225, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109382
        PubMed      DOI
    2.(2R,6R)-hydroxynorketamine targeting the basolateral amygdala regulates fear memory

    Author: Xu, Yuanyuan; Yu, Zhenfei; Chen, Si; Li, Zhenlong; Long, Xiting; Chen, Mengxu; Lee, Chau-Shoun; Peng, Hsien-Yu; Lin, Tzer-Bin; Hsieh, Ming-Chun; Lai, Cheng -Yuan; Chou, Dylan
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 225, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109402
        PubMed      DOI
    3.A role of GABAA receptor alpha 1 subunit in the hippocampus for rapid-acting antidepressant-like effects of ketamine

    Author: Tang, Xiao-Hui; Diao, Yu-Gang; Ren, Zhuo-Yu; Zang, Yan-Yu; Zhang, Guang-Fen; Wang, Xing-Ming; Duan, Gui-Fang; Shen, Jin-Chun; Hashimoto, Kenji; Zhou, Zhi-Qiang; Yang, Jian-Jun
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 225, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109383
        PubMed      DOI
    4.NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research

    Author: Lv, Shiyun; Yao, Kejie; Zhang, Youyi; Zhu, Shujia
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 225, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109378
        PubMed      DOI
    5.Ketamine and its metabolites: Potential as novel treatments for depression

    Author: Zhang, Kai; Yao, Yitan; Hashimoto, Kenji
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 222, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109305
        PubMed      DOI
    6.Accumbal adenosine A2A receptor inactivation biases for large and costly rewards in the effort- but not delay-based decision making

    Author: Sun, Xiaoting; Liu, Min; Xu, Xinyu; Shi, Chennan; Zhang, Liping; Yao, Zhimo; Chen, Jiangfan; Wang, Qin
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 222, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109273
        PubMed      DOI
    7.Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice

    Author: Gao, Feng; Wang, Juan; Yang, Shaojie; Ji, Manman; Zhu, Guoqi
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 222, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109306
        PubMed      DOI
    8.Role of purinergic receptors in cardiac sympathetic nerve injury in diabetes mellitus

    Author: Hu, Qixing; Li, Guilin
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 226, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109406
        PubMed      DOI
    9.Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease

    Author: Ribeiro, Deidiane Elisa; Petiz, Lyvia Lintzmaier; Glaser, Talita; Oliveira-Giacomelli, Agatha; Andrejew, Roberta; Saab, Fernando de Azevedo Ribeiro; Milanis, Milena da Silva; Campos, Henrique Correia; Sampaio, Vanessa Fernandes Arnaud; La Banca, Sophia; Longo, Beatriz Monteiro; Lameu, Claudiana; Tang, Yong; Resende, Rodrigo Ribeiro; Ferreira, Sergio T.; Ulrich, Henning
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 226, Issue , pp. -. DOI: 10.1016/j.neuropharm.2022.109371
        PubMed      DOI
    10.hr Striatopallidal adenosine A2A receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibility

    Author: Chen, Jiang -Fan; Choi, Doo-Sup; Cunha, Rodrigo A.
    Journal: NEUROPHARMACOLOGY. 2023; Vol. 226, Issue , pp. -. DOI: 10.1016/j.neuropharm.2023.109421
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共80条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451